These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6472015)

  • 1. Biology of tumors and head and neck cancer chemotherapy.
    Gussack GS; Brantley BA; Farmer JC
    Laryngoscope; 1984 Sep; 94(9):1181-7. PubMed ID: 6472015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic drug resistance in the management of head and neck cancer.
    Bier H
    Eur Arch Otorhinolaryngol; 1993; 250(4):200-8. PubMed ID: 8369114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent regimen of chemotherapy for advanced head and neck carcinomas].
    Tsukuda M
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):341-7. PubMed ID: 10740626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-line chemotherapy in head and neck cancer: what should we expect?
    Büntzel J; Micke O
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):269-73. PubMed ID: 19275504
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrating novel agents into the curative treatment of head and neck cancer.
    Haddad R; Allen A; Wirth L; Tishler R; Posner M
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):157-9. PubMed ID: 16445367
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of docetaxel in treatment of squamous-cell carcinoma of head and neck].
    Subramanian S; Kanagavel D; Petenko NN; Orlova KV; Samoĭlenko IV; Demidov LV
    Vopr Onkol; 2011; 57(4):421-6. PubMed ID: 22191228
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
    Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential chemosurgery for advanced head and neck cancer: another pathway in a complex maze?
    Robbins KT
    Ann Surg Oncol; 2003 Jul; 10(6):593-5. PubMed ID: 12839842
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoadjuvant cisplatin for head and neck cancer: Simulation of a novel schedule for improved therapeutic ratio.
    Marcu LG; Bezak E
    J Theor Biol; 2012 Mar; 297():41-7. PubMed ID: 22182756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Head and neck: molecular-targeted therapy].
    Tsukuda M
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1034-9. PubMed ID: 17682304
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of unknown primary squamous cell carcinoma in the neck showing a high response with combined chemotherapy including nedaplatin, adriamycin and 5-fluorouracil].
    Yamashita S; Hirao M; Tsujinaka T; Sawamura T; Nakamori S; Mishima H; Fujitani K; Ikenaga M; Kashiwazaki M; Masuda N
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1149-51. PubMed ID: 16121918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric flow cytometry of human squamous cell carcinoma lines from the head and neck.
    Wustrow TP; Raffael A; Valet G
    Otolaryngol Head Neck Surg; 1988 Jun; 98(6):552-7. PubMed ID: 3138611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemoradiotherapy for patients with advanced head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.
    Huang SM; Harari PM
    Clin Cancer Res; 2000 Jun; 6(6):2166-74. PubMed ID: 10873065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting epidermal growth factor receptor to optimize chemoradiotherapy in locally advanced head and neck cancer: has biology been taken into account?
    Herchenhorn D; Ferreira CG
    J Clin Oncol; 2011 Apr; 29(10):e283-4; author reply e285-7. PubMed ID: 21300921
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
    Rodriguez-Pinilla M; Rodriguez-Peralto JL; Hitt R; Sanchez JJ; Ballestin C; Diez A; Sanchez-Verde L; Alameda F; Sanchez-Cespedes M
    Clin Cancer Res; 2004 Dec; 10(24):8486-92. PubMed ID: 15623629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.
    Urba SG; Forastiere AA; Wolf GT; Esclamado RM; McLaughlin PW; Thornton AF
    J Clin Oncol; 1994 May; 12(5):946-53. PubMed ID: 8164046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Critical remarks on chemotherapy of malignant tumors of the head and neck].
    Ganzer U; Bier H; Bachert C
    Laryngol Rhinol Otol (Stuttg); 1987 Apr; 66(4):200-4. PubMed ID: 2439860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of squamous cell carcinoma of the head and neck.
    Greenberg BR
    Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.